Ricardo D Parrondo Selected Research

RNA Splicing Factors

1/2023

IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ricardo D Parrondo Research Topics

Disease

13	Multiple Myeloma 01/2024 - 01/2020
4	Neoplasms (Cancer) 01/2023 - 01/2020
2	Immunoglobulin Light-chain Amyloidosis 10/2023 - 12/2020
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2022 - 10/2020
2	Residual Neoplasm 01/2022 - 01/2020
1	Cytokine Release Syndrome 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Exanthema (Rash) 10/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Plasma Cell Leukemia 01/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Bone Diseases (Bone Disease) 01/2019

Drug/Important Bio-Agent (IBA)

4	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2021
3	Proteasome InhibitorsIBA 01/2021 - 01/2020
2	Bispecific AntibodiesIBA 01/2024 - 12/2020
2	idecabtagene vicleucelIBA 10/2023 - 01/2022
2	Chimeric Antigen ReceptorsIBA 10/2023 - 12/2020
2	AntibodiesIBA 10/2023 - 12/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 10/2022
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2022
2	ibrutinibIBA 10/2022 - 01/2022
2	Immunomodulating AgentsIBA 12/2020 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 01/2019
1	PENTAIBA 01/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2023
1	B-Cell Maturation AntigenIBA 10/2023
1	gossypol acetic acidIBA 01/2023
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	RNA Splicing FactorsIBA 01/2023
1	venetoclaxIBA 07/2022
1	ixazomibIBA 03/2021
1	daratumumabIBA 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 12/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 12/2020
1	Immunoconjugates (Immunoconjugate)IBA 12/2020
1	Immunoglobulin M (IgM)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	APOBEC-1 DeaminaseIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Denosumab FDA Link 01/2019
1	CytokinesIBA 01/2019
1	LigandsIBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2024 - 01/2020
5	Cell Transplantation 10/2023 - 10/2020
2	Immunotherapy 10/2023 - 12/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Autologous Transplantation 01/2022 - 01/2021
1	Transplantation 01/2021
1	Salvage Therapy 01/2020
1	Stem Cell Transplantation 01/2020